| Product Code: ETC9375318 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Antimicrobial Resistance Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa Antimicrobial Resistance Market - Industry Life Cycle |
3.4 South Africa Antimicrobial Resistance Market - Porter's Five Forces |
3.5 South Africa Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 South Africa Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 South Africa Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 South Africa Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 South Africa Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in South Africa |
4.2.2 Rising awareness regarding the importance of antimicrobial stewardship |
4.2.3 Government initiatives to combat antimicrobial resistance |
4.3 Market Restraints |
4.3.1 Limited access to appropriate healthcare facilities in certain regions of South Africa |
4.3.2 Lack of standardized guidelines for antimicrobial use |
4.3.3 High cost associated with development and deployment of antimicrobial resistance solutions |
5 South Africa Antimicrobial Resistance Market Trends |
6 South Africa Antimicrobial Resistance Market, By Types |
6.1 South Africa Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 South Africa Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 South Africa Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 South Africa Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 South Africa Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 South Africa Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 South Africa Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 South Africa Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 South Africa Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 South Africa Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 South Africa Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 South Africa Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 South Africa Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 South Africa Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 South Africa Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Africa Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 South Africa Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 South Africa Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 South Africa Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 South Africa Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 South Africa Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 South Africa Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 South Africa Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 South Africa Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 South Africa Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 South Africa Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 South Africa Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 South Africa Antimicrobial Resistance Market Export to Major Countries |
7.2 South Africa Antimicrobial Resistance Market Imports from Major Countries |
8 South Africa Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage of healthcare facilities implementing antimicrobial stewardship programs |
8.2 Number of government policies or initiatives focused on antimicrobial resistance |
8.3 Rate of adherence to antimicrobial prescribing guidelines in healthcare settings |
9 South Africa Antimicrobial Resistance Market - Opportunity Assessment |
9.1 South Africa Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 South Africa Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 South Africa Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 South Africa Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 South Africa Antimicrobial Resistance Market - Competitive Landscape |
10.1 South Africa Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 South Africa Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here